• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA• Launch preparations are underway to bring the second approved golimumab biosimilar to patients acro...
View DetailsAvzivi® (BAT1706) is Bio-Thera Solution’second FDA approved product in the United StatesAvzivi® is the second biosimilar researched,developed, and manufactured by a Chinese pharmaceutical company to receive FDAapproval in the United StatesGuangzhou, ...
Theclinical comparative study met its primary endpoint and showed similar efficacyand comparable safety profile in patients with moderate to severe plaque psoriasisGUANGZHOU,China, November 29, 2023 /PRNewswire/ -- Bio-Thera Solutions, Ltd. (688177:S...
GUANGZHOU,China, October 24, 2023 -- Bio-Thera Solutions, Ltd (688177:SH), acommercial-stage biopharmaceutical company developing a pipeline of biosimilarsand innovative assets, announced that the National Health Surveillance Agency(“ANVISA”) publish...
